Clinical trial
Arterial Hypertension With PARP Inhibitors in Cancer Patients: an Observational and Retrospective Study Using the WHO Pharmacovigilance Database (ArteRIB)
NCT04774406 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Arterial Hypertension With PARP Inhibitors in Cancer Patients: an Observational and Retrospective Study Using the WHO Pharmacovigilance Database (ArteRIB)
- Lead sponsor
- University Hospital, Caen
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 24, 2021
- Completion date
- September 1, 2022
- Enrollment
- 2,336 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer